Notice on the Supplementary Situation of Publicized Drugs in Hebei Province

According to the centralized procurement of drugs throughout the province, from April 28, 2019 to May 8, the approved pharmaceutical and manufacturing enterprises were publicized and questioned and clarified. Please login to Hebei Pharmaceutical Centralized Purchasing Network, enter the drug approval platform with user name and password, and check it in the "Internal Notification Bulletin" column.
Question and clarification materials should be related documents, approval, explanation, screenshot of official website, etc. If the material is unrecognizable or forged, all the consequences will be borne by the enterprise itself. Drugs whose quotation is lower or equal to the lowest networking/winning bid price of other provinces (cities) are publicized by networking; drugs whose quotation is higher than the lowest networking/winning bid price of other provinces (cities) are disqualified from networking; drugs whose price has not been inquired into are suspended for the time being. Enterprises are allowed to make complaints and then verify them according to their complaints.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
Two departments issued a document to guidethe strengthening of drug cases investigation and handling
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
-
244 medical device concept stocks roseindustry insiders said the process of domestic replacement is expected toaccelerate
-
Rare diseases pose a challenge to thepharmaceutical industry
Recommend Reading
-
Moldova Proposes Stricter Quality Standards for Edible Casein and Caseinates
-
Continental Tires Out, Franchise Power In: Continental Group Spins Off French Retail Arm to ASC in Strategic Pivot
-
“Oil Sheikhs” Buy Germany’s Chemical Crown: A €14.7 Billion Green Gamble or a Power Play in the Age of Carbon Neutrality?
-
From “10,000-Ton Bet” to “5,000-Ton Test”: Acore’s Polyetheramine Dilemma—Is This a Symptom of Industry Winter or the Prelude to Strategic Retreat?
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
-
This Week's Styrene Market Weakens and Falls (12.15-12.19)
-
Supply Increase Released, October Acrylonitrile Prices Fall to New Lows for the Year in China
-
Today, PET polyester bottle flakes rebound strongly (12.19)
-
Premium Global Chemical Sourcing Requests (27-31 Oct 2025)
-
High Supply Remains Firm, Weakness in ABS Market Persists at End of October in China